Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 27 Nov 2024

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study

in Cancer Immunity and Immunotherapy

Luigi Liguori
Gabriele Giorgio
Giovanna Polcaro
Valentina Pagliara
Domenico Malandrino
Francesco Perri
Marco Cascella
Alessandro Ottaiano
Valeria Conti
Alberto Servetto

Frontiers in Immunology

doi 10.3389/fimmu.2024.1419544

1,594 views

Original Research

Published on 27 Nov 2024

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

in Cancer Immunity and Immunotherapy

Yingtao Lin
Cijuan Li
Chang Wang
Jian Chen
Yuanqing Huang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1481584

856 views

Review

Published on 27 Nov 2024

c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity

in Cancer Immunity and Immunotherapy

Parham Jabbarzadeh Kaboli
Ghazaal Roozitalab
Reyhaneh Farghadani
Zoya Eskandarian
Abdessamad Zerrouqi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1498391

3,421 views
1 citation

Original Research

Published on 26 Nov 2024

A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy

in Cancer Immunity and Immunotherapy

Yang Li
Yinan Ding
Jinghao Wang
Xiaoxia Wu
Dinghu Zhang
Han Zhou
Pengfei Zhang
Guoliang Shao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1466069

1,473 views

Original Research

Published on 26 Nov 2024

Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model

in Cancer Immunity and Immunotherapy

Alaa Alsalloum
Saleh Alrhmoun
Olga Perik-Zavosdkaia
Marina Fisher
Marina Volynets
Julia Lopatnikova
Roman Perik-Zavodskii
Julia Shevchenko
Julia Philippova
Olga Solovieva

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507218

1,863 views

Original Research

Published on 26 Nov 2024

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)

in Cancer Immunity and Immunotherapy

Xilin Qu
Qian Wang
Fengfeng Zhu
Hao Liang
Zhangtao Long
Yachen Wu
Mengliang Jiang
Zhaohai Liu
Xiaoming Dai
Zhu Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1436315

1,221 views

Review

Published on 26 Nov 2024

Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Mingxin Guo
Wentong Fang
Zhiqiang Hu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1429483

1,384 views

Clinical Trial

Published on 26 Nov 2024

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients

in Cancer Immunity and Immunotherapy

Jonas S. Heitmann
Susanne Jung
Marcel Wacker
Yacine Maringer
Annika Nelde
Jens Bauer
Monika Denk
Naomi Hoenisch-Gravel
Marion Richter
Melek T. Oezbek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1482715

1,412 views

Original Research

Published on 26 Nov 2024

FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study

in Cancer Immunity and Immunotherapy

Yan-Cen Lu
Yu-Chen Yang
Di Ma
Jun-qing Wang
Feng-Jie Hao
Xu-xiao Chen
Yong-jun Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1471017

1,249 views
1 citation

Correction

Published on 26 Nov 2024

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

in Cancer Immunity and Immunotherapy

Chenghao Fu
Haonan Du
Qiang Wang
Weiyou Zhu
Guangli Bian
Zhujuan Zhong
Yuheng Wang
Lei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527232

375 views
1 citation

Original Research

Published on 26 Nov 2024

PRKDC regulates cGAMP to enhance immune response in lung cancer treatment

in Cancer Immunity and Immunotherapy

Zhanghao Huang
Runqi Huang
Jun Zhu
Youlang Zhou
Jiahai Shi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497570

1,237 views

Case Report

Published on 26 Nov 2024

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

in Cancer Immunity and Immunotherapy

Haijuan Yu
Jie Lin
Jian Chen
Lijun Chen
Jianping Zou
Bin Liu
Dan Hu
Youping Xiao
Linhao Yu
Yang Sun

Frontiers in Immunology

doi 10.3389/fimmu.2024.1494138

1,046 views

Original Research

Published on 26 Nov 2024

Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer

in Cancer Immunity and Immunotherapy

Gaofeng Qin
Zengkuan Chen
Weihong Tian
Hongbo Chen
Yu Zhang
Wangzhi Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1492531

1,189 views

Mini Review

Published on 26 Nov 2024

Reprogramming the tumor microenvironment – macrophages emerge as key players in breast cancer immunotherapy

in Cancer Immunity and Immunotherapy

Ana Sami
Afsheen Raza

Frontiers in Immunology

doi 10.3389/fimmu.2024.1457491

1,976 views

Case Report

Published on 26 Nov 2024

Case report: The outcomes of neoadjuvant immunotherapy combined with chemotherapy in pulmonary sarcomatoid carcinoma: case series and literature review

in Cancer Immunity and Immunotherapy

Xiaokang Guo
Jingjing Wang
Daosheng Li
Bin Wang
Hui Zhu
Hongbo Guo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467755

1,146 views

Review

Published on 26 Nov 2024

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials

in Cancer Immunity and Immunotherapy

Ke Ren
Hayam Hamdy
Abdo Meyiah
Eyad Elkord

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501613

1,073 views
1 citation

Navigation group

Articles

Checkpoint based immunotherapy in non-small cell lung cancer: a real-world retrospective study

Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US

c-MET and the immunological landscape of cancer: novel therapeutic strategies for enhanced anti-tumor immunity

A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy

Decoding NY-ESO-1 TCR T cells: transcriptomic insights reveal dual mechanisms of tumor targeting in a melanoma murine xenograft model

Research hotspots and trends in immunotherapy for cholangiocarcinoma: a bibliometric analysis (2014-2023)

Traditional Chinese medicine and its components effectively reduce resistance mediated by immune checkpoint inhibitors

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients

FOLFOX-HAIC combined with targeted immunotherapy for initially unresectable hepatocellular carcinoma: a real-world study

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

PRKDC regulates cGAMP to enhance immune response in lung cancer treatment

A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report

Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer

Reprogramming the tumor microenvironment – macrophages emerge as key players in breast cancer immunotherapy

Case report: The outcomes of neoadjuvant immunotherapy combined with chemotherapy in pulmonary sarcomatoid carcinoma: case series and literature review

Lymphocyte-activation gene 3 in cancer immunotherapy: function, prognostic biomarker and therapeutic potentials